247
Views
0
CrossRef citations to date
0
Altmetric
Research Article

How older Canadians access medical cannabis and information about it: A descriptive survey

ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, & show all
Article: 2303502 | Received 08 May 2023, Accepted 04 Jan 2024, Published online: 24 Jan 2024

References

  • Arora, K., Qualls, S. H., Bobitt, J., Milavetz, G., & Kaskie, B. (2021). Older cannabis users are not all alike: Lifespan cannabis use patterns. Journal of Applied Gerontology, 40(1), 87–16. https://doi.org/10.1177/0733464819894922
  • Ashforth, B. E., & Kreiner, G. E. (1999). “How can you do it ?”: Dirty work and the challenge constructing a positive identity. Academy of Management Review, 26(3), 413–434. https://doi.org/10.5465/amr.1999.2202129
  • Balneaves, L. G., Alraja, A., Ziemianski, D., McCuaig, F., & Ware, M. (2018). A national needs assessment of Canadian nurse practitioners regarding cannabis for therapeutic purposes. Cannabis and Cannabinoid Research, 3(1), 66–73. https://doi.org/10.1089/can.2018.0002
  • Baumbusch, J., & Yip, I. S. (2021). Exploring new use of cannabis among older adults. Clinical Gerontologist, 44(1), 25–31. https://doi.org/10.1080/07317115.2020.1746720
  • Bobitt, J., Qualls, S. H., Schuchman, M., Wickersham, R., Lum, H. D., Arora, K., Milavetz, G., & Kaskie, B. (2019a). Qualitative analysis of cannabis use among older adults in Colorado. Drugs & Aging, 36(7), 655–666. https://doi.org/10.1007/s40266-019-00665-w
  • Bobitt, J., Qualls, S. H., Schuchman, M., Wickersham, R., Lum, H. D., Arora, K., Milavetz, G., & Kaskie, B. (2019b). Qualitative analysis of cannabis use among older adults in Colorado. Drugs & Aging, 36(7), 655–666. https://doi.org/10.1007/s40266-019-00665-w
  • Butler, J. I., Dahlke, S., Devkota, R., Shrestha, S., Hunter, K. F., Toubiana, M., Kalogirou, M. R., Law, J., & Scheuerman, M. (2023). The information-seeking behavior and unmet knowledge needs of older medicinal cannabis consumers in Canada: A qualitative descriptive study. Drugs and Aging, 40(5), 427–438. https://doi.org/10.1007/s40266-023-01030-8
  • Chandiok, K., Marathe, S., Rooney, M., Stocker, J., Tellis, B., & Pit, S. (2021). Cannabis and its therapeutic value in the ageing population: Attitudes of health-care providers. Australasian Journal on Ageing, 40(3), 261–274. https://doi.org/10.1111/ajag.12846
  • Clarke, H., & Fitzcharles, M. (2023). The evolving culture of medical cannabis in Canada for the management of chronic pain. Frontiers in Pharmacology, 14, 1–11. https://doi.org/10.3389/fphar.2023.1153584
  • Corsonello, A., Pedone, C., & Incalzi, R. (2010). Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Current Medicinal Chemistry, 17(6), 571–584. https://doi.org/10.2174/092986710790416326
  • Cox, C. (2018). The Canadian cannabis act legalizes and regulates recreational cannabis use in 2018. Health Policy, 122(3), 205–209. https://doi.org/10.1016/j.healthpol.2018.01.009
  • Erickson, P. G., Van Der Maas, M., & Hathaway, A. D. (2013). Revisiting deterrence: Legal knowledge, use context and arrest perception for cannabis. Sociologicky Casopis, 49(3), 427–448. https://doi.org/10.13060/00380288.2013.49.3.04
  • Garcia, J. A., Crocker, J., & Wyman, J. F. (2005). Breaking the cycle of stigmatization. Managing the stigma of incontinence in social interactions. Journal of Wound, Ostomy, and Continence Nursing, 32(1), 38–52. https://doi.org/10.1097/00152192-200501000-00009
  • Government of Canada. (2001). Marihuana medical access regulations. Canada Gazette, Part, II, 135(14)SOR/2001–227. https://gazette.gc.ca/rp-pr/p2/2001/2001-07-04/pdf/g2-13514.pdf
  • Government of Canada. (2012). Marihuana for medical purposes regulations. Canada Gazette, Part I, 146(50). https://gazette.gc.ca/rp-pr/p1/2012/2012-12-15/html/reg4-eng.html
  • Government of Canada. (2016). Access to cannabis for Medical Purposes Regulations. https://gazette.gc.ca/rp-pr/p2/2016/2016-08-24/html/sor-dors230-eng.html
  • Government of Canada. (2019). ARCHIVED-Marked Data Under the Access to Cannabis for Medical Purposes Regulations. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/licensed-producers/market-data.html
  • Hazekamp, A., Ware, M. A., Muller-Vahl, K. R., Abrams, D., & Grotenhermen, F. (2013). The medicinal use of cannabis and cannabinoids-An international cross-sectional survey on administration forms. Journal of Psychoactive Drugs, 45(3), 199–210. https://doi.org/10.1080/02791072.2013.805976
  • Health Canada. (2016). Understanding the New Access to Cannabis for Medical Purposes Regulations. https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/understanding-new-access-to-cannabis-for-medical-purposes-regulations.html
  • Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288. https://doi.org/10.1177/1049732305276687
  • IBM. (2011). IBM SPSS statistics, release 20.0.0. Armonk, NY: IBM Corp.
  • Ishida, J. H., Zhang, A. J., Steigerwald, S., Cohen, B. E., Vali, M., & Keyhani, S. (2020). Sources of information and beliefs about the health effects of marijuana. Journal of General Internal Medicine, 35(1), 153–159. https://doi.org/10.1007/s11606-019-05335-6
  • Jones, K. P., & King, E. B. (2014). Managing concealable stigmas at work: A review and multilevel model. Journal of Management, 40(5), 1466–1494. https://doi.org/10.1177/0149206313515518
  • Kamrul, R., Bunka, D., Crawley, A., Schuster, B., & LeBras, M. (2019). Navigating cannabinoid choices for chronic neuropathic pain in older adults potholes and highlights. Canadian Family Physician, 65(11), 807–811.
  • Kaskie, B., Ayyagari, P., Milavetz, G., Shane, D., & Arora, K. (2017). The increasing use of cannabis among older Americans: A public health crisis or viable policy alternative? The Gerontologist, 57(6), 1166–1172. https://doi.org/10.1093/geront/gnw166
  • Kaufmann, C. N., Kim, A., Miyoshi, M., & Han, B. H. (2022). Patterns of medical cannabis use among older adults from a cannabis dispensary in New York state. Cannabis and Cannabinoid Research, 7(2), 224–230. https://doi.org/10.1089/can.2020.0064
  • Khoury, R., Maliha, P., & Ibrahim, R. (2022). Cannabis use and misuse in older adults. Clinics in Geriatric Medicine, 38(1), 67–83. https://doi.org/10.1016/j.cger.2021.07.003
  • Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Reviews Soiciology, 27(1), 363–385. https://doi.org/10.1146/annurev.soc.27.1.363
  • Lowry, D. E., & Corsi, D. J. (2020). Trends and correlates of cannabis use in Canada: A repeated cross-sectional analysis of national surveys from 2004 to 2017. CMAJ Open, 8(3), E487–E495. https://doi.org/10.9778/cmajo.20190229
  • Lum, H. D., Arora, K., Croker, J. A., Qualls, S. H., Schuchman, M., Bobitt, J., Milavetz, G., & Kaskie, B. (2019). Patterns of marijuana use and health impact: A survey among older coloradans. Gerontology and Geriatric Medicine, 5, 233372141984370. https://doi.org/10.1177/2333721419843707
  • Mahvan, T. D., Hilaire, M. L., Mann, A., Brown, A., Linn, B., Gardner, T., & Lai, B. (2017). Marijuana use in the elderly: Implications and considerations. The Consultant Pharmacist, 32(6), 341–351. https://doi.org/10.4140/TCP.n.2017.341
  • Manning, L., & Bouchard, L. (2021). Medical cannabis use: Exploring the perceptions and experiences of older adults with chronic conditions. Clinical Gerontologist, 44(1), 32–41. https://doi.org/10.1080/07317115.2020.1853299
  • Meisenbach, R. J. (2010). Stigma management communication: A theory and agenda for applied research on how individuals manage moments of stigmatized identity. Journal of Applied Communication Research, 38(3), 268–292. https://doi.org/10.1080/00909882.2010.490841
  • Smith, L. A., Azariah, F., Lavender, V. T., Stoner, N. S., & Bettiol, S. (2015). Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews, 2015(11), 1–83. https://doi.org/10.1002/14651858.CD009464.pub2
  • Statistics Canada. (2019). National Cannabis Survey, Third Quarter 2019. https://www150.statcan.gc.ca/n1/en/daily-quotidien/191030/dq191030a-eng.pdf?st=cfBYp9SD
  • Sun Life Financial. (2018). Medical cannabis and group benefits plan coverage. https://www.sunlife.ca/static/canada/Sponsor/AboutGroupBenefits/Groupbenefitsproductsandservices/TheConversation/BrightPapers/files/BrightPaperMedicalCannabisPDF8090E_Final.pdf
  • Tumati, S., Lanctôt, K. L., Wang, R. D., Li, A., Davis, A., & Herrmann, N. (2022). Medical cannabis use among older adults in Canada: Self-reported data on types and amount used, and perceived effects. Drugs and Aging, 39(2), 153–163. https://doi.org/10.1007/s40266-021-00913-y
  • Yang, K. H., Kaufmann, C. N., Nafsu, R., Lifset, E. T., Nguyen, K., Sexton, M., Han, B. H., Kim, A., & Moore, A. A. (2021). Cannabis: An emerging treatment for common symptoms in older adults. Journal of the American Geriatrics Society, 69(1), 91–97. https://doi.org/10.1111/jgs.16833
  • Ziemianski, D., Capler, R., Tekanoff, R., Lacasse, A., Luconi, F., & Ware, M. A. (2015). Cannabis in medicine: A national educational needs assessment among Canadian physicians. BMC Medical Education, 15(1), 1–7. https://doi.org/10.1186/s12909-015-0335-0